ArticleAlzheimer's & dementia (New York, N. Y.)

Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease.

Maria L Faquetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.